EUVIMED · CrossrefJournal
Atherosclerosis Supplements
ISSN 1567-5688 · Elsevier BV
Latest articles
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia
Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives
Large artery stiffness according to different assessment methods in adult population of St.Petersburg
Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS Studies
The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia
CaRe high – Cascade screening and registry for high cholesterol in Germany
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)
How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy
Increasing HDL-cholesterol and prevention of atherosclerosis: A critical perspective
The effect of ezetimibe on NAFLD
Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cells
Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension
32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT
Retinal vessel analysis in hypercholesterolemic patients before and after LDL apheresis
Postprandial dyslipidemia in insulin resistance: Mechanisms and role of intestinal insulin sensitivity
Trans fatty acids and insulin resistance
CVD risk factors and ethnicity—A homogeneous relationship?
We-P14:429 Despite its instability, epigallocatechin gallate effective lowers serum cholesterol in the hypercholesterolaemic rabbit
What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome?
Do pregnancy complications and CVD share common antecedents?
Comparative pharmacology of rosuvastatin
High risk/high priority: familial hypercholesterolemia — a paradigm for molecular medicine
Cardiovascular risk—through the ages
HDL: a recipe for longevity
Gene therapy and CVD: how near are we?
Insights from apoB: from better diagnosis & therapy to the Medusa Hypothesis
Impact of age on cardiovascular risk: implications for cardiovascular disease management
EUVIMED